Raloxifene - Usual, Raloxifene - Study — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-18 in 3mo
ESTIMATED |
READOUT
Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymo
Phase 2/3 · Breast Cancer |
Han Xu, M.D., Ph.D., FAPCR, Sponso | Raloxifene - Usual, Raloxifene - Study |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|